Close

Anti-STAT6 DNA-encoded mAb (DMAb), pVAX1 (DMAb-3098-CQ)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-STAT6 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • STAT6
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 6778
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-3098-CQ CBXS-1734 Mouse IgG2a Recombinant human STAT6, Asn341-Gly640, Accession # P42226.1
DMAb-3099-CQ YE361 Rabbit IgG
DMAb-3100-CQ CBXS-3765 Mouse IgG1 A portion of amino acids 600-650 of human STAT6
DMAb-3101-CQ CBXS-4629 Mouse IgG Synthetic peptide towards STAT6
DMAb-3102-CQ CBXS-3556 Human IgG1
DMAb-3103-CQ CBXS-1117 Mouse IgG1 Recombinant Human STAT6 protein
DMAb-3104-CQ CBXS-5801 Mouse IgG2b Recombinant protein corresponding to aa 695-804 of human STAT6
DMAb-3105-CQ CBXS-4271 Rabbit IgG Peptide corresponding to amino acids 630-638 of human singal transducer and activator of transcription 6
DMAb-3106-CQ CBXS-5259 Mouse IgG1 Purified recombinant fragment of human STAT6
DMAb-3107-CQ CBXS-5276 Mouse IgG1
DMAb-3108-CQ CBXS-0761 Mouse IgG2b
DMAb-3109-CQ CBXS-1101 Mouse IgG2a Recombinant Human STAT6 protein
DMAb-3110-CQ CBXS-1451 Rabbit IgG
DMAb-3111-CQ CBXS-1669 Rabbit IgG Phosphopeptide containing human STAT6 Y641 site. Accession # P42226
DMAb-3112-CQ CBXS-1890 Rat IgG2a Recombinant mouse STAT6, Ser627-Trp837, Accession # P52633
DMAb-3113-CQ CBXS-1987 Rat IgG2a Phosphopeptide containing the human STAT6 Y641 site, Accession # P42226
DMAb-3114-CQ CBXS-1988 Rat IgG2b Phosphopeptide containing the human STAT6 Y641 site, Accession # P42226
DMAb-3115-CQ CBXS-2119 Mouse
DMAb-3116-CQ CBXS-2122 Mouse
DMAb-3117-CQ CBXS-2164 Mouse
DMAb-3118-CQ CBXS-2473 Mouse IgG1 Purified recombinant fragment of human STAT6
DMAb-3119-CQ CBXS-3251 Mouse STAT6 (NP_003144, 694aa-801aa) partial recombinant protein with GST tag
DMAb-3120-CQ CBXS-3365 Mouse IgG1 Synthetic peptide corresponding to aa 630-650 of human STAT6
DMAb-3121-CQ CBXS-3396 Mouse IgG2a Recombinant protein corresponding to human STAT6
DMAb-3122-CQ CBXS-3452 Mouse Partial sequence of recombinant Full length protein to human STAT 6
DMAb-3123-CQ CBXS-6148 Rabbit IgG

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-STAT6 DNA-encoded mAb (DMAb), pVAX1 (DMAb-3098-CQ). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.